ADRED – Adverse drug reactions (ADR) leading to emergency department (ED) visits: Causality analysis and preventability rate of the ADRs
- Conditions
- Y57T88.0Other and unspecified drugs and medicamentsInfection following immunization
- Registration Number
- DRKS00008979
- Lead Sponsor
- Forschungsabteilung BfArM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9000
Patients with adverse drug reactions (ADRs), which needed a treatment in an emergency department. In these cases, it comes to enrollment after positive causality assessment of ADRs by the physician.
Age =18 years.
Capacity to consent and written informed consent of the patient.
Patients treated in the emergency center without UAW by using home medication. (after causality assessment by a health professional in the emergency room).
Intentional ingestion of inappropriate drugs or doses, by the patients themselves, which have led to the adverse effect (eg. As with suicidal intent).
Age <18 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary target is the occurrence of at least one avoidable ADRs (Adverse Drug Reaction) per patient, which have led to hospital emergency treatment.<br><br>The classification of ADRs as avoidable (medication errors) is being edited with a work of score called Schumock et al. (1992). <br>
- Secondary Outcome Measures
Name Time Method 1) Possible causes of preventable ADRs, which have led to hospital emergency treatment:<br>Medication errors types and causes (eg. As dose omission, incorrect application form, wrong patient et cetera.)<br><br>2) Possible causes of non-preventable ADRs, which have led to hospital emergency treatment:<br>• Patient-related factors (gender, age, comorbidity et cetera.)<br>• Pharmacogenetic causes of ADRs<br><br>3) consequences of ADRs:<br>• Clinical course and severity of the clinical consequences<br>• number of deaths within the observation period<br>• Pharmacoeconomic implications of ADRs / medication errors<br>